Loma Linda University
Loma Linda, California, 92350, United States
NCT Number: NCT07257042
The objective of this study is to assess clinical efficacy of a toothpaste containing 8% arginine (Colgate-Palmolive Company, New York, NY, USA) to provide dental hypersensitivity relief (tactile and air blast) in comparison to Colgate Cavity Protection Toothpaste (Colgate-Palmolive Company, New York, NY, USA) over an eight-week period.
Looking for future studies?
Notify Me18 year–70 year
All sexes
Interventional
Phase 3
Loma Linda, California, 92350, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Brush twice daily (morning and evening) for one full minute Cover the entire length of bristles with toothpaste
Brush twice daily (morning and evening) for one full minute Cover the entire length of bristles with toothpaste
Time frame: Baseline 4 week & 8 week
Sensitivity will be defined by a score in the range of 10-50 gms. of force
Time frame: Baseline 4 week & 8 week
Sensitivity will be defined by a score of 2 or 3 on the Schiff Cold Air Sensitivity Scale
Colgate Palmolive
Industry
The Clinical Investigation of a Toothpaste Containing 8% Arginine Compared to Colgate Cavity Protection Toothpaste in Reducing Dentinal Hypersensitivity - an Eight-week Clinical Study in the US
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03553251
Beta Lactam Adverse Reaction, Hypersensitivity
Nantes, Loire-Atlantique, France
View Trial DetailsNCT03679676
Food Allergy, Food Hypersensitivity
Los Angeles, California, United States
View Trial DetailsNCT05039229
Asthma, Asthma, Occupational
Tromsø, Norway
View Trial DetailsNCT01407640
Allergy, Autoimmune Diseases
Paris, France
View Trial Details